Home » Topics » BioWorld Science

BioWorld Science
RSS

Transgene and BioInvent report preclinical data on BT-001 for solid tumors

Dec. 12, 2019

Positive early phase I data for Genmab's CD3xCD20 bispecific antibody GEN-3013

Dec. 12, 2019

Novel FVIII mimetic bispecific antibody Mim8 exhibits preclinical efficacy against hemophilia A

Dec. 12, 2019

Discovery and preclinical characterization of novel DHODH inhibitors for AML

Dec. 12, 2019

CYT-0853 demonstrates promising activity in models of autoimmune disease

Dec. 12, 2019

NCKAP1 as a new therapeutic target in ALS

Dec. 12, 2019

VRG-50014 rescues ALS phenotypes in preclinical models

Dec. 12, 2019

Lilly initiates phase III LIBRETTO-431 study of selpercatinib

Dec. 12, 2019

CBDVHS demonstrates enhanced antiseizure activity compared to CBD

Dec. 12, 2019

AST-008 demonstrates activity in patients with MCC

Dec. 12, 2019

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...